Co-Diagnostics
CODX
#10919
Rank
NZ$9.4 M
Marketcap
NZ$2.57
Share price
0.00%
Change (1 day)
509.70%
Change (1 year)

Revenue for Co-Diagnostics (CODX)

Revenue in 2026 (TTM): NZ$1.22 Million

According to Co-Diagnostics 's latest financial reports the company's current revenue (TTM ) is NZ$1.22 Million. In 2025 the company made a revenue of NZ$1.07 Million a decrease over the revenue in the year 2024 that were of NZ$6.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Co-Diagnostics from 2016 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) NZ$1.22 M14.2%
2025 NZ$1.07 M-83.62%
2024 NZ$6.56 M-39.09%
2023 NZ$10.77 M-80.01%
2022 NZ$53.89 M-62.39%
2021 NZ$0.14 B38.7%
2020 NZ$0.10 B32269.86%
2019 NZ$0.31 M436.47%
2018 NZ$0.05 M451.52%
2017 NZ$0.01 M-25.27%
2016 NZ$0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
PAVmed
PAVM
NZ$0.14 M-88.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Philips
PHG
NZ$35.19 B 2,878,139.11%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands